about
Personalization of the immunosuppressive treatment in renal transplant recipients: the great challenge in "omics" medicinePharmacogenomics in clinical practice: reality and expectationsPharmacogenomic information in drug labels: European Medicines Agency perspective.Integrating molecular diagnostics into histopathology training: the Belfast model.Impact of direct-to-consumer genomic testing at long term follow-up.
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on January 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Pathology practice and pharmacogenomics.
@en
Pathology practice and pharmacogenomics.
@nl
type
label
Pathology practice and pharmacogenomics.
@en
Pathology practice and pharmacogenomics.
@nl
prefLabel
Pathology practice and pharmacogenomics.
@en
Pathology practice and pharmacogenomics.
@nl
P2860
P356
P1433
P1476
Pathology practice and pharmacogenomics.
@en
P2093
Ronald Ja Trent
P2860
P304
P356
10.2217/PGS.09.150
P577
2010-01-01T00:00:00Z